Skip to main content

Elmind Capital, LP

Source: SEC Form 13F · as of Mar 2026

Elmind Capital, LP holds 33 biotech & pharma companies tracked by BioSniper, totaling $350.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

33

Total value held

$350.8M

BioSniper AIPage evidence connected

Prepared research question

What matters most for Cogent Biosciences, Inc. (COGT)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
COGTCogent Biosciences, Inc.1,170,740$45.1M
SNDXSyndax Pharmaceuticals Inc1,855,000$43.3M
CLDXCelldex Therapeutics, Inc.865,000$27.4M
CTMXCytomX Therapeutics, Inc.4,550,000$21.4M
KALVKalVista Pharmaceuticals, Inc.1,021,300$20.6M
CGONCG Oncology, Inc.291,800$19.7M
VERAVera Therapeutics, Inc.482,500$19.4M
PCVXVaxcyte, Inc.316,500$18.4M
PHVSPharvaris N.V.475,750$13.4M
TYRATyra Biosciences, Inc.350,000$13.4M
BEAMBeam Therapeutics Inc.476,338$11.4M
VRDNViridian Therapeutics, Inc.\DE534,931$10.5M
BCRXBIOCRYST PHARMACEUTICALS INC1,000,000$9.5M
UTHRUNITED THERAPEUTICS Corp15,000$8.9M
CGEMCullinan Therapeutics, Inc.530,000$7.5M
NRIXNurix Therapeutics, Inc.460,000$7.1M
MBXMBX Biosciences, Inc.211,000$6.3M
KRYSKrystal Biotech, Inc.22,000$5.7M
DBVTDBV Technologies S.A.265,000$5.5M
RLAYRelay Therapeutics, Inc.536,946$5.3M
TVTXTravere Therapeutics, Inc.177,600$5.3M
PTGXProtagonist Therapeutics, Inc38,000$4.0M
URGNUroGen Pharma Ltd.220,000$4.0M
ALMSALUMIS INC.130,000$2.9M
BMRNBIOMARIN PHARMACEUTICAL INC47,000$2.7M
DSGNDesign Therapeutics, Inc.207,900$2.2M
APLSApellis Pharmaceuticals, Inc.50,000$2.0M
ALECAlector, Inc.900,000$1.9M
IMCRImmunocore Holdings plc58,248$1.8M
AMLXAmylyx Pharmaceuticals, Inc.112,000$1.6M
WVEWave Life Sciences Ltd.177,846$1.3M
SUPNSUPERNUS PHARMACEUTICALS, INC.20,000$1.0M
EWTXEdgewise Therapeutics, Inc.10,000$315K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.